Lotus Eye Hospital reported a profit of Rs 0.08 crore for FY 2025-26, down from Rs 0.74 crore, as it prioritized network expansion with a new center in Gobichettipalayam. The company also regularized governance issues and proposed salary revisions for top management.
Lotus Eye Hospital FY26 Profit Drops to Rs 0.08 Crore
Revenue grew to Rs 53.71 crore; Profit After Tax fell to Rs 0.08 crore.
Reader Takeaway: Revenue growth highlights market reach expansion, while heavy startup costs for new facilities squeezed bottom-line margins.
What just happened
Lotus Eye Hospital and Institute Ltd released its annual report for FY 2025-26, revealing a period of significant operational expansion. The company commissioned a new eye care center in Gobichettipalayam, Erode District. While operational revenue increased to Rs 53.71 crore from Rs 49.56 crore in the previous year, overall profitability took a hit, declining to Rs 0.08 crore compared to Rs 0.74 crore in FY 2024-25.
Why this matters
The company’s focus on scaling its network, which now spans 10 centers across Tamil Nadu and Kerala, reflects a long-term growth strategy. The associated expansion costs impacted net margins for the year. Shareholders are now looking toward these new assets to improve earnings potential in the coming quarters.
Management and Board Developments
The board has proposed a salary hike for Managing Director Sangeetha Sundaramoorthy, increasing her remuneration to Rs 6 lakh per month starting August 2026. Additionally, the company appointed Mr. Prathish S as the new Company Secretary and Compliance Officer in February 2026.
Risks to watch
The company faced regulatory friction regarding the appointment of Dr. K.S. Ramalingam. The firm paid Rs 10.24 lakh in fines to the BSE and NSE for non-compliance with SEBI Regulation 17(1A). Management has clarified that the matter was regularized following a shareholder postal ballot in January 2026.
What to track next
Investors should monitor the revenue contribution from the new Gobichettipalayam unit and evaluate if the increased management remuneration correlates with improved bottom-line performance in the new fiscal year.
